DNA methylation and gene silencing in cancer: which is the guilty party?
- PMID: 12154400
- DOI: 10.1038/sj.onc.1205598
DNA methylation and gene silencing in cancer: which is the guilty party?
Abstract
The DNA methylation pattern of a cell is exquisitely controlled during early development resulting in distinct methylation patterns. The tight control of DNA methylation is released in the cancer cell characterized by a reversal of methylation states. CpG island associated genes, in particular tumour suppressor or related genes, are often hypermethylated and this is associated with silencing of these genes. Therefore methylation is commonly convicted as a critical causal event in silencing this important class of genes in cancer. In this review, we argue that methylation is not the initial guilty party in triggering gene silencing in cancer, but that methylation of CpG islands is a consequence of prior gene silencing, similar to the role of methylation in maintaining the silencing of CpG island genes on the inactive X chromosome. We propose that gene silencing is the critical precursor in cancer, as it changes the dynamic interplay between de novo methylation and demethylation of the CpG island and tilts the balance to favour hypermethylation and chromatin inactivation.
Similar articles
-
Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.Cancer Res. 2004 Jun 1;64(11):3871-7. doi: 10.1158/0008-5472.CAN-03-3690. Cancer Res. 2004. PMID: 15172996
-
Dormant hypermethylated tumour suppressor genes: questions and answers.J Pathol. 2005 Jan;205(2):172-80. doi: 10.1002/path.1707. J Pathol. 2005. PMID: 15643671 Review.
-
Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.Hum Mol Genet. 2009 Aug 15;18(16):3098-109. doi: 10.1093/hmg/ddp251. Epub 2009 May 28. Hum Mol Genet. 2009. PMID: 19477956
-
Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells.Oncogene. 2002 Feb 7;21(7):1048-61. doi: 10.1038/sj.onc.1205153. Oncogene. 2002. PMID: 11850822
-
Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.Hum Mol Genet. 2007 Apr 15;16 Spec No 1:R88-95. doi: 10.1093/hmg/ddm051. Hum Mol Genet. 2007. PMID: 17613553 Review.
Cited by
-
Promoter and histone methylation and p16(INK4A) gene expression in colon cancer.Exp Ther Med. 2012 Nov;4(5):865-870. doi: 10.3892/etm.2012.683. Epub 2012 Aug 24. Exp Ther Med. 2012. PMID: 23226740 Free PMC article.
-
Epigenetics of cervical cancer. An overview and therapeutic perspectives.Mol Cancer. 2005 Oct 25;4:38. doi: 10.1186/1476-4598-4-38. Mol Cancer. 2005. PMID: 16248899 Free PMC article. Review.
-
Folate deficiency regulates expression of DNA polymerase β in response to oxidative stress.Free Radic Biol Med. 2011 Jan 15;50(2):270-80. doi: 10.1016/j.freeradbiomed.2010.11.003. Epub 2010 Nov 8. Free Radic Biol Med. 2011. PMID: 21070850 Free PMC article.
-
Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth.Oncotarget. 2014 Oct 30;5(20):9744-55. doi: 10.18632/oncotarget.2403. Oncotarget. 2014. PMID: 25313138 Free PMC article.
-
Epigenetic regulation of prostate cancer.Genes Dis. 2019 Nov 9;7(4):606-613. doi: 10.1016/j.gendis.2019.10.018. eCollection 2020 Dec. Genes Dis. 2019. PMID: 33335960 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
